Topics

Add-On Molecule May Boost CAR T-Cell Activity

09:30 EST 8 Nov 2019 | MedPageToday

(MedPage Today) -- NATIONAL HARBOR, Md. -- Chimeric antigen receptor (CAR) T cells "armored" with an anti-PD-1 molecule led to objective responses in 12 of 13 patients with relapsed/refractory non-Hodgkin's lymphoma (NHL) in a preliminary clinical...

Original Article: Add-On Molecule May Boost CAR T-Cell Activity

NEXT ARTICLE

More From BioPortfolio on "Add-On Molecule May Boost CAR T-Cell Activity"

Quick Search